Re:Sputnik V vaccine peer reviewed with efficacy of 91.6%
by tzs on Wednesday February 03, 2021 @05:38PM
(#26020147)
What about the vaccines that made it through phase I and II trials fine, but then in phase III were found to not be very effective? That happened to GSK, Sanofi, and Merck (twice for Merck).
If vaccines were widely deployed after phase II with no proof they actually work, there would have be some that did not work that got widely used. The people that got them would they have immunity, and slack off on distancing and masking.
Once you did have a vaccine that you knew worked, there would probably be problems convincing those who got an ineffective vaccine that they need to come in again.
If vaccines were widely deployed after phase II with no proof they actually work, there would have be some that did not work that got widely used. The people that got them would they have immunity, and slack off on distancing and masking.
Once you did have a vaccine that you knew worked, there would probably be problems convincing those who got an ineffective vaccine that they need to come in again.